Eurofins BioPharma Product Testing Denmark Holding A/S

CVR 37064408 · Public limited company (A/S) · Active · Low risk

Eurofins BioPharma Product Testing Denmark Holding A/S is a Public limited company (A/S), founded on , based in Galten. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 11 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 24.8m and a net result of DKK 8.4m.

Bankruptcy risk for Eurofins BioPharma Product Testing Denmark Holding A/S

0.5%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 60% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
37064408
Status
Active
Company type
Public limited company (A/S)
Founded
(11 years)
Address
Smedeskovvej 38
8464 Galten
Municipality
Skanderborg
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 500k
Auditor
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late0 of 11
Missing annual reportNo
Negative equityNo
Equity ratio34.9%
Current ratio1,608%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address30
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK -163kDKK -104kDKK -93k
Net profitDKK 8.4mDKK -1.9mDKK 3.6m
EquityDKK 24.8mDKK 16.4mDKK 20.1m
Total assetsDKK 71.0mDKK 62.8mDKK 66.5m
Short-term debtDKK 817kDKK 899k–
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025174
1 Jan 2024 – 31 Dec 2024153
1 Jan 2023 – 31 Dec 2023149
1 Jan 2022 – 31 Dec 2022156
1 Jan 2021 – 31 Dec 2021151
1 Jan 2020 – 31 Dec 2020165
1 Jan 2019 – 31 Dec 2019183
1 Jan 2018 – 31 Dec 2018148
1 Jan 2017 – 31 Dec 2017165
1 Jan 2016 – 31 Dec 2016170
31 Aug 2015 – 31 Dec 2015158

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
BoardSvend Aage LindeCurrent
BoardJan RandoCurrent
BoardMarco Antonio Giuseppe BaeliCurrent
BoardThomas Gjelsnes
BoardBerthold Jakob Georg Hackl
BoardJacob Klinge Jacobsen
Owner (100%)Eurofins Pharma Services LUX Holding SARLCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderEurofins Pharma Services LUX Holding SARLCurrent

Address history (1 moves)

Smedeskovvej 38, 8464 Galten
Ørnebjergvej 1, 2600 Glostrup

Former names

Eurofins BioPharma Product Testing Denmark Holding A/S – now
Eurofins BioPharma Product Testing & Professional Scientific Services Denmark Holding A/S –
Eurofins Pharma Holding Denmark A/S –

Other companies at the same address

Similar companies in Skanderborg

Questions and answers about Eurofins BioPharma Product Testing Denmark Holding A/S

Has Eurofins BioPharma Product Testing Denmark Holding A/S gone bankrupt?

No, Eurofins BioPharma Product Testing Denmark Holding A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Eurofins BioPharma Product Testing Denmark Holding A/S?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the auditor of Eurofins BioPharma Product Testing Denmark Holding A/S?

Eurofins BioPharma Product Testing Denmark Holding A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Eurofins BioPharma Product Testing Denmark Holding A/S founded?

Eurofins BioPharma Product Testing Denmark Holding A/S was founded on 31 August 2015.

What is the equity of Eurofins BioPharma Product Testing Denmark Holding A/S?

Equity was DKK 24.8m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.